Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
The CAS number for BPC-157 is 137525-51-0
Trimi's compounded semaglutide uses the same active pharmaceutical ingredient but is prepared per individual prescription by a 503A compounding pharmacy and isn't reviewed by the FDA for safety, effectiveness, or quality before marketing
It is a weekly injectable medication and is FDA-approved to treat Type 2 diabetes, but is sometimes prescribed off-label for weight loss like its brand-name counterpart
The blend can be administered subcutaneously near the site of interest or intraperitoneally for systemic distribution
People see others with similar struggles around food, cravings, and life stress, and they learn practical skills, not just rules
(81) and Thorel et al
